Abstract
A cross-sectional study was conducted to evaluate monoamine oxidase type B (MAO-B) activity in platelets as a biomarker of effect of styrene and perchloroethylene exposures. MAO-B is an enzyme system involved in dopamine catabolism, the impairment of which has been postulated as a mechanism of styrene-induced neurotoxicity. We previously observed an inverse association between blood styrene and MAO-B among reinforced plastics manufacturing workers. The present study included 59 male boat plant workers exposed to styrene (exposure range < 1–144 ppm, 8-h TWA). Two comparison groups comprised six male dry cleaning workers exposed to perchloroethylene (PCE; exposure range < 2-37 ppm) and 14 male laundry workers not exposed to either agent. Respiratory protection was not used by any of the styrene- or PCE-exposed workers; thus, air concentrations were regarded as valid exposure indicators. MAO-B activity (pmol/108 cells/h) was measured in peripheral blood platelets, using phenylethylamine as substrate. Only small overall mean differences in MAO-B were observed among the three groups; mean values were 4.21, 4.51, and 4.12 for the styrene-exposed, PCE-exposed, and laundry workers, respectively. Despite the absence of gross differences among the groups, styrene exposure was inversely related to MAO-B. Mean values for four increasing exposure group quartiles were: 5.60, 4.13, 3.69, and 3.44. The Spearman rank correlation coefficient for styrene with MAO-B was −0.41. Adjustment for age, medication use, smoking, and alcohol consumption had only a minimal effect on this trend. Duration of exposure to styrene bore a weak positive relation to MAO-B (Spearman r = + 0.29), which was nearly entirely explained by collinearity with age. The results from this study are in close quantitative agreement with previous findings of an inverse association between styrene exposure and MAO-B. More agents need to be evaluated to establish specificity, and longitudinal analyses of styrene-exposed workers will be required before confident conclusions can be reached about the predictive value of MAO-B as a biomarker of styrene-related neurotoxicity.
Similar content being viewed by others
References
Arfini G, Mutti A, Vescovi P, et al. (1987) Impaired dopaminergic modulation of pituitary secretion in workers occupationally exposed to styrene: further evidence from PRL response to TRH stimulation. J Occup Med 29:826–830
Checkoway H,Costa LG, Camp J, Coccini T, Daniell W, Dills R (1992a) Peripheral markers of neurochemical function among styrene-exposed workers. Br J Ind Med 1992; 49:560–565
Checkoway H, Costa LG, Woods JS, Castoldi AF, Lund BO, Swanson PD (1992b) Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease. J Neural Transmission [P-D Sect] 4:283–290
Cherrie N, Gautrin D (1990) Neurotoxic effects of styrene: further evidence. Br J Ind Med 47:29–37
Corash L, Shafer B, Perlow M (1979) Heterogeneity of human whole blood platelet subpopulations. II. Use of a subhuman primate model to analyze the relationship between density and platelet age. Blood 52:726–734
Danielczyk W, Steiffler M, Konradi C, Riederer P, Moll G (1988) Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia. Acta Psychiatr Scand 78:730–736
Dills RL, Kent SD, Checkoway H, Kalman DA (1991) Quantitation of volatile solvents in blood using static headspace analysis. Talanta 38:365–374
Edling C, Edberg K (1985) No acute behavioural effects of exposure to styrene: a safe level of exposure? Br J Ind Med 42:301–304
Flodin U, Ekberg K, Andersson L (1989) Neuropsychiatric effects of low exposure to styrene. Br J Ind Med 46:805–808
Hamet P, Fraysse T, Franks DL (1978) Cyclic nucleotides and aggregation of platelets of spontaneously hypertensive rats. Circ Res 43:583–591
Harkonen H, Lindstrom K, Seppalainen AM, Asp S, Hernberg S (1978) Exposure-response relationships between styrene exposure and central nervous functions. Scand J Work Environ Health 4 (Suppl 2):104–113
Humfrey CDN, Steventon GB, Sturman SG, Waring RH, Griffiths B, Williams AC (1990) Monoamine oixidase substrates in Parkinson's disease. Biochem Pharmacol 40:2562–2564
Jegaden D, Amann D, Simon JF, Habault M, Legoux B, Galopin P (1993) Study of neurobehavioural toxicity of styrene at low levels of exposure. Int Arch Occup Environ Hyg 64:527–531
Kleinbaum DG, Kupper LL, Muller KM (1988) Applied regression analysis and other multivariable methods, 2nd edn. PWS, Boston
Lee DH, Mendoza M, Dvorozniak MT, et al. (1989) Platelet monoamine oxidase in Parkinson patients: effect of L-deprenyl therapy. J Neural Transmission [P-D Sect] 1:189–194
Lilis R, Lorimer WV, Diamond S, Selikoff IJ (1978) Neurotoxicity of styrene in production and polymerization workers. Environ Res 15:133–138
National Institute for Occupational Safety and Health [NIOSH] (1984, 1987) NIOSH manual of analytic methods, 3rd edn. U.S. Department of Human and Health Services. U.S. Government Printing Office, Washington, DC
Romanelli, A, Falzoi M, Mutti A, Bergamaschi E, Franchini I (1986) Effects of some monocyclic aromatic solvents and their metabolites on brain dopamine in rabbits. J Appl Toxicol 6:431–435
Triebig G, Lehrl S, Welte D, Schaller K, Valentin H (1989) Clinical and neurobehavioural study of the acute and chronic neurotoxicity of styrene. Br J Ind Med 46:799–804
Young WF, Laws ER, Sharbrough FW, Weinshilboum RM (1986) Human monoamine oxidase—lack of brain and platelet correlation. Arch Gen Psychiatry 43:604–609
Zaidi N, Agrawal AK, Srivastava SP, Seth SP (1985) Effect of gestational and neonatal styrene exposure on dopamine receptors. Neurobehav Toxicol Teratol 7:23–28
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Checkoway, H., Echeverria, D., Moon, JD. et al. Platelet monoamine oxidase B activity in workers exposed to styrene. Int. Arch Occup Environ Heath 66, 359–362 (1994). https://doi.org/10.1007/BF00378370
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00378370